SCHEMBL7302646

SCHEMBL7302646

CC(C)(C)ONC(=O)[C@H](CSc1ccc(Oc2ccccc2)cc1)NC(=O)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.52
MMP13 P45452 1/20 0.50
CTSK P43235 9/20 0.49
CTSS P25774 4/20 0.49
CTSL P07711 4/20 0.46
CTSB P07858 2/20 0.46
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
CASP1 P29466 1/20 0.44
ITGB3 P05106 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7302654 1.00 CA2 (0.52) CA2MMP13CTSKCTSSCTSL
SCHEMBL7309215 0.85 PPARA (0.55) CA2MMP13CTSKCTSSCASP1
SCHEMBL7309224 0.85 PPARA (0.55) CA2MMP13CTSKCTSSCASP1
SCHEMBL7303933 0.81 MMP13 (0.76) MMP13CTSKCTSSCTSLCTSB
SCHEMBL7303925 0.81 MMP13 (0.76) MMP13CTSKCTSSCTSLCTSB
SCHEMBL4673137 0.80 MMP13 (0.49) MMP13CTSKCTSSCTSLCTSB
SCHEMBL4673130 0.80 MMP13 (0.49) MMP13CTSKCTSSCTSLCTSB
SCHEMBL6576404 0.76 KYNU (0.58) CA2MMP13CTSKCTSSCTSL
SCHEMBL4968729 0.76 KYNU (0.58) CA2MMP13CTSKCTSSCTSL
SCHEMBL7564546 0.76 KYNU (0.58) CA2MMP13CTSKCTSSCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed